Bond Screener
Abbott Laboratories
LEI HQD377W2YR662HK5JX27, SWIFT ABTTUS44XXX
Organization name
Abbott Laboratories
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
32,295 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
|
General information
-
Organization nameAbbott Laboratories
-
Organization statusOperating organization
-
Address100 Abbott Park Road AP6D-2 D312 Abbott Park Green Oaks, USA, 60064
-
Site
-
IR Site
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameAbbott Laboratories
-
Organization statusOperating organization
-
Address100 Abbott Park Road AP6D-2 D312 Abbott Park Green Oaks, USA, 60064
-
Site
-
IR Site
Codes
-
LEIHQD377W2YR662HK5JX27
-
SWIFTABTTUS44XXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0000001800
-
EIN36-0698440
